Visit
for coverage from TIME, Health, Fortune and more
Go »
Memory doubts
Memory doubts GSO Images—Getty Images

A Drug Has Been Found That Reverses a Precursor to Alzheimer's

Mar 12, 2015
TIME Health
For more, visit TIME Health.

Researchers at John Hopkins University have found that low doses of a drug more commonly used to treat epilepsy can reverse a condition that increases the risk of developing Alzheimer's disease.

According to statements issued Wednesday, the epilepsy drug, called antiepileptic levetiracetam, calms hyperactivity in the brain — a well-documented symptom of people with amnestic mild cognitive impairment, which is a condition that heightens the possibility of developing Alzheimer’s disease.

The team, lead by neuroscientist Michela Gallagher, now wants to pursue substantial clinical trials.

“What we want to discover now, is whether treatment over a longer time will prevent further cognitive decline and delay or stop progression to Alzheimer’s dementia,” Gallagher said.

The researchers studied 84 people with an average age of 70. Participants received various doses of the drug, as well as a placebo, and the scientists used imaging technology to map brain activity.

All products and services featured are based solely on editorial selection. TIME may receive compensation for some links to products and services on this website.